NICE backs Lundbeck's Selincro for alcohol consumption

The U.K.'s NICE issued Selincro nalmefene from H. Lundbeck A/S (CSE:LUN) to help reduce alcohol consumption in adults who are heavy drinkers but do not require immediate detoxification. The European Commission approved Selincro to reduce alcohol consumption in adults with alcohol dependence last year. Comments are due July 29. Final guidance is expected in November. ...